Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Orexigen Therapeutics, Inc. (OREX)

-NasdaqGS
5.29 Down 0.10(1.86%) 4:00PM EDT
|After Hours : 5.26 Down 0.03 (0.57%) 5:22PM EDT - Nasdaq Real Time Price
Prev Close:5.39
Open:5.41
Bid:5.25 x 500
Ask:5.31 x 1000
1y Target Est:11.63
Beta:1.78
Earnings Date:Aug 4 - Aug 8 (Est.)
Day's Range:5.27 - 5.48
52wk Range:4.60 - 7.84
Volume:2,923,997
Avg Vol (3m):3,368,220
Market Cap:615.37M
P/E (ttm):N/A
EPS (ttm):-0.82
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
OREXDown 1.86%615.37M
ABTUp 0.30%64.72B
GSKDown 0.32%128.10B
RHHBYUp 0.30%250.16B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):182.91
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.11
Quarterly EPS Est (Jun-14) :-0.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.14

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Orexigen Therapeutics, Inc., a biopharmaceutical company, focuses on the development of pharmaceutical product candidates for the treatment of obesity. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback